Glucocorticoids such as dexamethasone phosphate applied locally exert a pronounced effect in adult hay fever patients (Norman and Winkenwerder, 1965) . A depot steroid injection gives similar results (Ganderton, Brostoff, and Frankland, 1969) . However, since corticosteroids so administeredl affect adrenal function their use in children for such a minor disorder as hay fever is usually unjustifiable. Recently it has been shown that the local application of beclomethasone dipropionate is an efficient treatment of nasal symptoms in adults with hay fever (Mygind, 1973) , perennial rhinitis (Hansen and Mygind, 1974; Gibson et al., 1974) , and nasal polyps . As the daily dose used in these trials has been shown not to suppress adrenal function we felt justified in using the drug intranasally in children suffering from The nasal aerosol spray used was the commercially available preparation Beconase, which delivers 50 ,tg beclomethasone dipropionate with each spray. The dose was one spray into each nostril four times a day. One nasal aerosol spray was given to every patient for each 2-week period. By assessing the number of sprays contained in 10 aerosols the mean was found to be 231 with a range of 212 to 237. The children and their parents were carefully instructed in the correct use of the aerosol emphasizing that only the prescribed dose should be used each day. One discharge of the aerosol into the air was allowed to ensure that it functioned correctly.
The children were allocated at random in a doubleblind fashion to two groups, one of which initially received the active drug and the other the placebo. (Martin, Harrison, and Tanner, 1975) .
Results
Because the weather was cold and rainy during the trial the hay fever symptoms were mild. Nevertheless each patient had enough symptoms for a reliable evaluation of the cross-over treatments to be made.
Of the 18 children, 17 preferred the active drug, none preferred the placebo, and one had no preference. The symptom scores from the diary cards showed that the active aerosol nasal spray had had a pronounced beneficial effect on blocked nose, nasal secretion, and sneezing. The mean total daily scores for nasal and eye symptoms for both 2-week periods are shown in Table I . During the second week of treatment the total of nasal scores when the patients were receiving active drug was only 12% of those when they were using the placebo. The corresponding figure for the eye scores was 53%.
The total number of antihistamine tablets taken by patients using active drug during the last week of the trial was 26 compared with 145 taken by those using placebo-a difference of 82%. This difference is highly significant (P <0*0001). The corresponding figures for the use of eye drops were 41 and 104, a difference of 61%, which does not, however, reach the level of significance (P>0 05). Beclomethasone dipropionate did not act immediately but, as may be seen from the Fig. exerted a significant effect on the second day. The active drug was effective for some days after it had been discontinued, thus protecting the children from their usual early morning sneezing attacks. The only side effect noted was sneezing after using the aerosol. This was reported by 5 children when they used both the active and placebo aerosols. In no case was treatment stopped because of it. Beclomethasone dipropionate administered intranasally may therefore be said to be well tolerated by children.
The mean urinary 17-oxogenic steroid level was 23 * 9% lower during the active drug treatment period than during the placebo period (Table II) . However, this difference is not significant (P> 0 -1).
Assessment of the number of sprays left in the aerosols showed that 3 children had probably taken active drug and placebo in excess of the prescribed dose (Table III in nasal symptom scores were in the group taking too low a dose of the drug.
Discussion
The effect of the treatment in children with hay fever was even more pronounced than in adults (Mygind, 1973 between the different symptoms. The intranasal steroid had no effect on eye symptoms in adult hay fever patients (Mygind, 1973) . In this trial the drug was shown to have local rather than systemic activity, as indicated by the lack of significant fall in the urinary excretion of 17-oxogenic steroids. This correlates well with our findings in adult hay fever patients when treated intranasally with similar doses (Mygind, 1973) . Many trials have shown that a daily dose of 300 to 400 ,ug does not suppress adrenal function, as indicated by plasma cortisol estimation, in adult asthmatics (Lal et al., 1972; Chatterjee et al., 1972 , Maberly, Gibson, and Butler, 1973 Buisseret, 1973) . and the same applies to children (Brown and Storey, 1973; WilkenJensen, 1975) .
The daily dose used in this trial was possibly too high for some children since nasal symptoms were reduced by 90% in many of them and far fewer antihistamine tablets were taken. A doseresponse investigation has indicated, however, that the daily starting dose should be 400 ,ug in all hay fever patients (Andersen, Halberg, and Mygind, 1975) . Gibson et al. (1974) have shown that intranasal beclomethasone dipropionate 200 ,ug daily over a 3-week period improved the symptoms of adults suffering from perennial rhinitis without any evidence of adrenal suppression. Godfrey and Konig (1974) showed that inhaled beclomethasone dipropionate at doses varying from 100 to 600 ,ug/ day during their trials and for a maximum of 8 months' follow-up showed no evidence of suppressing either adrenal function or growth. Harris et al. (1974) have shown that when the drug is both inhaled and taken intranasally there is no clear evidence of adrenal suppression when the combined dose is less than 5 mg/day. It seems, therefore, that in severe cases of perennial rhinitis in children a trial of the drug is justified. In children with hay fever 400 ,ug/day beclomethasone dipropionate intranasally provides an efficient and safe treatment. The resulting reduction in antihistamine drug dosage is advantageous as many children suffer from their soporific side effectis. 
